"Gene Products, gag" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins coded by the retroviral gag gene. The products are usually synthesized as protein precursors or POLYPROTEINS, which are then cleaved by viral proteases to yield the final products. Many of the final products are associated with the nucleoprotein core of the virion. gag is short for group-specific antigen.
| Descriptor ID |
D015683
|
| MeSH Number(s) |
D12.776.775.330 D12.776.964.775.350 D12.776.964.970.600.850.350
|
| Concept/Terms |
Gene Products, gag- Gene Products, gag
- gag Polyprotein
- Polyprotein, gag
- gag Polyproteins
- Polyproteins, gag
- gag Protein
- Protein, gag
- Retroviral Antigen gag Protein
- Viral gag Proteins
- Proteins, Viral gag
- gag Proteins, Viral
- Gene Product, gag
- gag Gene Product
- gag Gene Products
- gag Antigens
- Antigens, gag
- gag Viral Proteins
- Proteins, gag Viral
- Viral Proteins, gag
|
Below are MeSH descriptors whose meaning is more general than "Gene Products, gag".
Below are MeSH descriptors whose meaning is more specific than "Gene Products, gag".
This graph shows the total number of publications written about "Gene Products, gag" by people in this website by year, and whether "Gene Products, gag" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 1 | 2 |
| 1999 | 0 | 1 | 1 |
| 2002 | 2 | 0 | 2 |
| 2003 | 2 | 0 | 2 |
| 2007 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gene Products, gag" by people in Profiles.
-
Nucleolar trafficking of the mouse mammary tumor virus gag protein induced by interaction with ribosomal protein L9. J Virol. 2013 Jan; 87(2):1069-82.
-
Gag localization and virus-like particle release mediated by the matrix domain of human T-lymphotropic virus type 1 Gag are less dependent on phosphatidylinositol-(4,5)-bisphosphate than those mediated by the matrix domain of HIV-1 Gag. J Virol. 2011 Apr; 85(8):3802-10.
-
Interaction between the human immunodeficiency virus type 1 Gag matrix domain and phosphatidylinositol-(4,5)-bisphosphate is essential for efficient gag membrane binding. J Virol. 2008 Mar; 82(5):2405-17.
-
HIV-1(89.6) Gag expressed from a replication competent HSV-1 vector elicits persistent cellular immune responses in mice. Vaccine. 2007 Sep 17; 25(37-38):6764-73.
-
Evidence for a new viral late-domain core sequence, FPIV, necessary for budding of a paramyxovirus. J Virol. 2005 Mar; 79(5):2988-97.
-
Induction of CD8+ T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriers. J Immunol. 2003 Dec 15; 171(12):6774-9.
-
Alpha interferon inhibits human T-cell leukemia virus type 1 assembly by preventing Gag interaction with rafts. J Virol. 2003 Dec; 77(24):13389-95.
-
Robust recall and long-term memory T-cell responses induced by prime-boost regimens with heterologous live viral vectors expressing human immunodeficiency virus type 1 Gag and Env proteins. J Virol. 2002 Aug; 76(15):7506-17.
-
High-level primary CD8(+) T-cell response to human immunodeficiency virus type 1 gag and env generated by vaccination with recombinant vesicular stomatitis viruses. J Virol. 2002 Mar; 76(6):2730-8.
-
HIV gag mRNA transfection of dendritic cells (DC) delivers encoded antigen to MHC class I and II molecules, causes DC maturation, and induces a potent human in vitro primary immune response. J Immunol. 2000 Oct 15; 165(8):4710-7.